Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Monoclonal Antibody

Anti-HBV HBcAg Monoclonal Antibody (1A244)

Catalog #:   MVV11502 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG
Applications: GICA
Overview

Catalog No.

MVV11502

Species reactivity

Hepatitis B virus (HBV)

Host species

Mouse

Isotype

IgG

Clonality

Monoclonal

Immunogen

HBV HBcAg Protein.

Target

Capsid protein, Core antigen, Core protein, HBcAg, p21.5, C

Concentration

1mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

GICA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

1A244

Data Image
References

Performance evaluation of the access anti-HBc IgM Assay on the DxI 9000 access immunoassay analyzer., PMID:40305958

Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B., PMID:40008890

Detection of hepatitis B virus surface antigen, IgM and IgG antibodies to hepatitis B virus core antigen in the clinical classification and epidemiological surveillance of HBV infection., PMID:39903324

Molecular and serological investigation of hepatitis B virus in patients with acute undifferentiated febrile illness at Tha Song Yang hospital, Tak Province, Thailand., PMID:39891087

A cell-penetrating bispecific antibody suppresses hepatitis B virus replication and secretion., PMID:39863173

Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection., PMID:39846714

Design of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approaches., PMID:39642099

Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation., PMID:39638038

Functional B cell deficiency promotes intrahepatic HBV replication and impairs the development of anti-HBV T cell responses., PMID:39630171

Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical Trials., PMID:39624922

Obtaining HBV core protein VLPs carrying SARS-CoV-2 nucleocapsid conserved fragments as vaccine candidates., PMID:39609857

The characterization and structural basis of a human broadly binding antibody to HBV core protein., PMID:39601613

Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy., PMID:39505254

Survival after liver transplantation from hepatitis B-core positive donors at a quaternary care hospital in Brazil., PMID:39401751

International review of blood donation screening for anti-HBc and occult hepatitis B virus infection., PMID:39359112

What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis., PMID:39206573

Anti-HBc mirrors the activation of HBV-specific CD8+ T cell immune response and exhibits a direct effect on HBV control., PMID:39089333

Quantitative HBV Core Antibodies as a Prognostic Marker for HBeAg Seroclearance: A Systematic Review with Meta-Analysis., PMID:39066283

Ex Vivo Fluorescent Labeling of HBV-Specific B Cells in Chronic Hepatitis B Patients., PMID:39044090

Incidences of new hepatitis B infection and anti-hepatitis B core-negative occult hepatitis B infection among Japanese blood donors in relation to anti-hepatitis B surface antigen levels., PMID:39039862

Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis B., PMID:38992769

Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee., PMID:38881210

Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature., PMID:38855800

Impact of Hepatitis B Surface and Core Antibody Levels on Hepatitis B Virus Reactivation., PMID:38735754

Early application of IFNγ mediated the persistence of HBV in an HBV mouse model., PMID:38556058

Blood donation screening for hepatitis B virus core antibodies: The importance of confirmatory testing and initial implication for rare blood donor groups., PMID:38419267

Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next?, PMID:38375981

De novo hepatitis B infection following liver transplantation with core antibody positive grafts: The role of surface antibody status in guiding long-term prophylaxis., PMID:38375953

A case-control study of risk factors for incident hepatitis B virus infection in South African blood donors., PMID:38373648

Breakthrough infection by hepatitis B virus in a vaccinated blood donor: An emerging threat for transfusion safety in low-endemic countries?, PMID:38345135

Suggested blood donor deferral strategy regarding hepatitis B infections in China., PMID:38258949

Seroreactivity of antibodies to hepatitis B core antigen among hepatitis B surface antigen-screened negative blood donors and its implications for blood safety in a resource-constrained country., PMID:38245853

Predictive value of hepatitis B serological indicators for mortality among cancer survivors and validation in a gastric cancer cohort., PMID:38150459

Expression and purification of Hepatitis B virus core antigen using Escherichia coli and its utilization for the diagnosis of Hepatitis B virus infections., PMID:37979341

Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors., PMID:37796091

Marked reduction in the incidence of transfusion-transmitted hepatitis B virus infection after the introduction of antibody to hepatitis B core antigen and individual donation nucleic acid amplification screening in Japan., PMID:37767806

Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders., PMID:37766155

Expanding the donor pool: Kidney transplantation from serum HBV DNA or HBeAg-positive donors to HBsAg-negative recipients., PMID:37592870

Development of Chimeric Hepatitis B (HBV) - Norovirus (NoV) P particle as candidate vaccine against Hepatitis B and norovirus infection., PMID:37519778

Atypical Hepatitis B Virus Serology Profile-Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative-In Hepatitis B Virus/HIV Coinfected Individuals in Botswana., PMID:37515230

World Hepatitis day 2021 -screening and vaccination against Hepatitis B virus in Accra, Ghana., PMID:37328849

Cross-Reactivity of HBe Antigen-Specific Polyclonal Antibody with HBc Antigen., PMID:37294935

Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections., PMID:37243197

Occult Hepatitis B Virus Infection and Liver Fibrosis in Chinese Patients., PMID:37170968

Transfusion-transmitted HBV infection with isolated anti-HBs-positive blood., PMID:37129363

Prevalence and awareness of Hepatitis B virus infection in the United States: January 2017 - March 2020., PMID:36996000

Antibodies to Hepatitis B core antigen prevalence study in Kazakhstan., PMID:36988253

Hepatitis B in Heart Transplant Donors and Recipients: A Systematic Review and Meta-Analysis., PMID:36914999

HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma., PMID:36847156

Hepatitis B prophylaxis among recipients of a hepatitis B core antibody positive liver transplant., PMID:36759305

Datasheet
$ 196
Product specifications
50 μg 196 100 μg 313

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-HBV HBcAg Monoclonal Antibody (1A244) [MVV11502]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only